Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Cyclin-dependent kinase 9' and Ligand = 'BDBM307984'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM307984 (N-{5-chloro-4-[1-(3-fluorobenzyl)-1H-benzimidazol-...) Show SMILES Fc1cccc(Cn2cnc3ccc(cc23)-c2cc(NC(=O)[C@H]3CCC(=O)N3)ncc2Cl)c1 Show InChI InChI=1S/C24H19ClFN5O2/c25-18-11-27-22(30-24(33)20-6-7-23(32)29-20)10-17(18)15-4-5-19-21(9-15)31(13-28-19)12-14-2-1-3-16(26)8-14/h1-5,8-11,13,20H,6-7,12H2,(H,29,32)(H,27,30,33)/t20-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	23	n/a	n/a	n/a	n/a	n/a	n/a
AbbVie Inc. US Patent					Assay Description CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in...				US Patent US9650358 (2017) BindingDB Entry DOI: 10.7270/Q2057J0M
					More data for this Ligand-Target Pair